FULGENT GENETICS, INC. Increase (Decrease) in Other Operating Assets
FULGENT GENETICS, INC. (FLGT) reported Increase (Decrease) in Other Operating Assets of -$5.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-07-30
- FULGENT GENETICS, INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$2.28M, a 597.82% decline year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$2.79M.
- FULGENT GENETICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$1.82M.
- FULGENT GENETICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $1.37M, a 0.73% increase year-over-year.
- FULGENT GENETICS, INC. increase (decrease) in other operating assets for fiscal 2025 was -$798.00K.
- FULGENT GENETICS, INC. increase (decrease) in other operating assets for fiscal 2024 was -$199.00K, a 105.97% decline from fiscal 2023.
- FULGENT GENETICS, INC. increase (decrease) in other operating assets for fiscal 2023 was $3.33M.
- FULGENT GENETICS, INC. increase (decrease) in other operating assets for fiscal 2022 was -$9.38M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$5.07M 10-Q · filed 2026-07-30 | -$6.89M derived: sum of 3 quarters · filed 2026-07-30 | -$5.52M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$2.79M 10-Q · filed 2026-05-01 | -$4.61M derived: sum of 2 quarters · filed 2026-05-01 | -$3.24M derived: sum of 3 quarters · filed 2026-05-01 | -$2.79M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$452.00K derived: sum of 2 quarters · filed 2026-02-27 | $6.00K derived: sum of 3 quarters · filed 2026-07-30 | -$798.00K 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.83M derived: sum of 2 quarters · filed 2026-07-30 | $1.02M 10-Q · filed 2025-11-07 | $250.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$346.00K 10-Q · filed 2026-07-30 | -$1.12M derived: sum of 3 quarters · filed 2026-07-30 | $240.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$804.00K 10-Q · filed 2026-05-01 | -$1.58M derived: sum of 2 quarters · filed 2026-05-01 | -$218.00K derived: sum of 3 quarters · filed 2026-05-01 | -$1.03M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | -$775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $586.00K derived: sum of 2 quarters · filed 2026-02-27 | -$223.00K derived: sum of 3 quarters · filed 2026-02-27 | -$199.00K 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $552.00K derived: sum of 2 quarters · filed 2025-11-07 | $576.00K 10-Q · filed 2025-11-07 | $1.50M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | -$809.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$785.00K 10-Q · filed 2025-08-01 | -$4.10M 10-Q · filed 2024-08-02 | $139.00K derived: sum of 3 quarters · filed 2026-02-27 | -$1.22M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-03-31 | $24.00K 10-Q · filed 2025-05-02 | -$5.13M 10-Q · filed 2024-05-03 | $948.00K derived: sum of 2 quarters · filed 2026-02-27 | -$409.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.73M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $924.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$433.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.70M derived: sum of 3 quarters · filed 2026-02-27 | $3.33M 10-K · filed 2026-02-27 | $572.00K 10-K · filed 2024-02-28 | |||
| 2023-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $778.00K derived: sum of 2 quarters · filed 2024-11-08 | $2.41M 10-Q · filed 2024-11-08 | $2.88M 10-Q · filed 2023-11-03 | -$3.25M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $3.76M 10-Q · filed 2024-08-02 | -$1.89M derived: sum of 3 quarters · filed 2025-02-28 | -$7.47M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $1.63M 10-Q · filed 2024-05-03 | -$4.03M derived: sum of 2 quarters · filed 2025-02-28 | -$9.61M derived: sum of 3 quarters · filed 2025-02-28 | -$4.79M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$11.23M derived: sum of 2 quarters · filed 2025-02-28 | -$6.42M derived: sum of 3 quarters · filed 2025-02-28 | -$9.38M 10-K · filed 2025-02-28 | $4.34M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$5.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$760.00K derived: sum of 2 quarters · filed 2023-11-03 | -$3.72M 10-Q · filed 2023-11-03 | -$13.61M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.85M 10-Q · filed 2023-08-04 | -$8.04M derived: sum of 3 quarters · filed 2024-02-28 | -$11.97M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | -$2.96M 10-Q · filed 2023-05-05 | -$12.85M derived: sum of 2 quarters · filed 2024-02-28 | -$16.79M derived: sum of 3 quarters · filed 2024-02-28 | -$19.88M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$9.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$13.83M derived: sum of 2 quarters · filed 2024-02-28 | -$16.91M derived: sum of 3 quarters · filed 2024-02-28 | -$7.80M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | -$3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$7.02M derived: sum of 2 quarters · filed 2022-11-07 | $2.09M 10-Q · filed 2022-11-07 | $4.06M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $6.03M 10-Q · filed 2022-08-04 | $8.00M derived: sum of 3 quarters · filed 2023-02-28 | $23.35M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $9.11M 10-Q · filed 2022-05-05 | $11.08M derived: sum of 2 quarters · filed 2023-02-28 | $26.43M derived: sum of 3 quarters · filed 2023-02-28 | $29.33M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $17.32M derived: sum of 2 quarters · filed 2023-02-28 | $20.23M derived: sum of 3 quarters · filed 2023-02-28 | $21.15M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $15.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $18.25M derived: sum of 2 quarters · filed 2021-11-09 | $19.18M 10-Q · filed 2021-11-09 | $19.25M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $3.83M 10-Q · filed 2021-08-10 | $3.90M derived: sum of 3 quarters · filed 2022-02-28 | $3.64M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $924.00K 10-Q · filed 2021-05-07 | $1.00M derived: sum of 2 quarters · filed 2022-02-28 | $733.00K derived: sum of 3 quarters · filed 2022-02-28 | $614.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$191.00K derived: sum of 2 quarters · filed 2022-02-28 | -$310.00K derived: sum of 3 quarters · filed 2022-02-28 | -$374.00K 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | -$267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$386.00K derived: sum of 2 quarters · filed 2020-11-09 | -$450.00K 10-Q · filed 2020-11-09 | -$326.00K derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$183.00K 10-Q · filed 2020-08-05 | -$59.00K derived: sum of 3 quarters · filed 2020-08-05 | -$252.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | -$64.00K 10-Q · filed 2020-05-06 | $60.00K derived: sum of 2 quarters · filed 2020-05-06 | -$133.00K derived: sum of 3 quarters · filed 2020-05-06 | -$280.00K derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$69.00K derived: sum of 2 quarters · filed 2020-03-13 | -$216.00K derived: sum of 3 quarters · filed 2020-03-13 | -$91.00K 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | -$193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$340.00K derived: sum of 2 quarters · filed 2019-11-08 | -$215.00K 10-Q · filed 2019-11-08 | |||||
| 2018-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$22.00K 10-Q · filed 2019-08-12 | ||||||
| 2018-03-31 | $125.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |